Articoli correlati a Cell Cycle Deregulation in Cancer

Cell Cycle Deregulation in Cancer ISBN 13: 9781441917690

Cell Cycle Deregulation in Cancer - Rilegato

 
9781441917690: Cell Cycle Deregulation in Cancer
Vedi tutte le copie di questo ISBN:
 
 

Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Dalla quarta di copertina:

Modern studies of regulation of the cell division cycle were pioneered by Leland Hartwell, Paul Nurse, and Tim Hunt in yeast and marine invertebrates. This work identified proteins termed cyclins that fluxuate in abundance during progression through the cycle and partner with Cyclin dependent kinases (Cdks) to drive major cell cycle transitions. Much has been learned since about how these and other proteins control cell cycle progression in all eukaryotes, including man. Further research is uncovering how these controls are de-regulated in cancer, a disease of unbridled cell proliferation that is the leading cause of death in developed countries. However, there is much more to be learned, and the hard won gains are just beginning to impact cancer care. In 11 reviews by leading experts, this volume lays out the current state and directions of the field for biomedical scientists of all training levels.

The collection begins with three reviews that delineate how cells initiate the cell cycle, from growth factor stimulation to activation of key transcription programs and origins of DNA replication. The next three reviews address issues of proliferation under duress, including how derangement of mitotic checkpoints can lead to cell death or genetic instability and how recycling of intracellular molecules (autophagy) is regulated. The next three reviews address the special context of long-term proliferation—how it is regulated in stem cells, how it can erode telomeric structures on the tips of chromosomes, and how it can culminate in senescence. The last two reviews describe how cell cycle advances are beginning to touch patients, in the characterization of pre-malignant states and in cancer therapy.

Contenuti:
Starting the cell division cycle Elena Sotillo and Xavier Graña Escape from cellular quiescence Jun-Yuan Ji and Nicholas J. Dyson Interplay between Cyclin-dependent Kinases and E2F-dependent Transcription. A. Kathleen McClendon, Jeffry L. Dean, and Erik S. Knudsen Regulation of pre-RC assembly: A complex symphony orchestrated by CDKs Proliferation under duress Haomin Huang and Timothy J Yen Mitotic checkpoint and chromosome instability in cancer Jeremy P.H. Chow and Randy Y.C. Poon Mitotic catastrophe Robert D. Hontz and Maureen E. Murphy p53, ARF and the control of autophagy Long-term proliferation Andrea Viale and Pier Giuseppe Pelicci Regulation of self-renewing divisions in normal and leukaemia stem cells Eros Lazzerini Denchi Maintenance of Telomeres in Cancer Peter D. Adams The senescence secretome and its impact on tumor suppression and cancer Applications in preventing and treating cancer Pierre Lao-Sirieix and Rebecca C Fitzgerald Cell cycle deregulation in pre-neoplasia: case study of Barrett’s esophagus Neil Johnson and Geoffrey I. Shapiro Targeting cyclin dependent kinases for cancer therapy

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

  • EditoreSpringer Nature
  • Data di pubblicazione2010
  • ISBN 10 1441917691
  • ISBN 13 9781441917690
  • RilegaturaCopertina rigida
  • Numero edizione1
  • Numero di pagine206
  • RedattoreEnders Greg H.

Altre edizioni note dello stesso titolo

9781461425694: Cell Cycle Deregulation in Cancer

Edizione in evidenza

ISBN 10:  ISBN 13:  9781461425694
Casa editrice: Springer, 2012
Brossura

  • 9781441917737: Cell Cycle Deregulation in Cancer

    Springer, 2011
    Brossura

I migliori risultati di ricerca su AbeBooks

Immagini fornite dal venditore

Editore: Springer (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: 10
Da:
booksXpress
(Bayonne, NJ, U.S.A.)
Valutazione libreria

Descrizione libro Hardcover. Condizione: new. Codice articolo 9781441917690

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 154,29
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Editore: Springer (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: > 20
Da:
Lucky's Textbooks
(Dallas, TX, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo ABLIING23Mar2411530293636

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 169,80
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,69
In U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Greg H. Enders
Editore: Springer (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: > 20
Print on Demand
Da:
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria

Descrizione libro Condizione: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Codice articolo ria9781441917690_lsuk

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 167,44
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,65
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Enders, Greg H. (EDT)
Editore: Springer (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: 1
Da:
GreatBookPricesUK
(Castle Donington, DERBY, Regno Unito)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo 8835807-n

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 164,48
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,50
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Greg H. Enders
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: 2
Print on Demand
Da:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germania)
Valutazione libreria

Descrizione libro Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy. 216 pp. Englisch. Codice articolo 9781441917690

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 160,49
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 23,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Enders, Greg H.
Editore: Springer New York (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: > 20
Print on Demand
Da:
moluna
(Greven, Germania)
Valutazione libreria

Descrizione libro Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.Includes supplementary material: sn.pub/extrasCancer is fundamentally a disease of abnormal cell pro. Codice articolo 4172369

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 136,16
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 48,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Greg H. Enders
Editore: Springer New York (2010)
ISBN 10: 1441917691 ISBN 13: 9781441917690
Nuovo Rilegato Quantità: 1
Da:
AHA-BUCH GmbH
(Einbeck, Germania)
Valutazione libreria

Descrizione libro Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy. Codice articolo 9781441917690

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 164,03
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 32,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi